Mohfw Issues advisory for rational use of Remdesivir for COVID-19 Treatment.

The Remdesivir is to be used only in select moderate/ severe hospitalised Covid – 19 patients on supplemental oxygen as it is a reserve drug approved under Emergency Use Authorization only based on limited scientific evidence globally and It is not indicated in mild Covid – 19 patients who are in home care/ Covid Care Centres.